Overview
- Zipporah Washington, 34, was diagnosed last winter with advanced non-Hodgkin lymphoma that had invaded her heart.
- Temple University Hospital created a personalized approach that paired aggressive chemotherapy with daily echocardiographic monitoring to protect cardiac function.
- She completed seven chemotherapy cycles, with initial treatments in the ICU, and summer scans showed her heart function returned to normal.
- Doctors report she is in remission; in June she rang the bell marking her final chemotherapy and graduated from nursing school with honors.
- She reunited with her Temple care team on Thursday, and she is considering a move to Philadelphia for follow-up as she pursues pediatric oncology nursing.